We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Gene Mutation Identified That Can Trigger Lymphoblastic Leukemia

By LabMedica International staff writers
Posted on 05 Jul 2015
Print article
Image: Blood smear of child with acute lymphoblastic leukemia (Photo courtesy of Ohio State University).
Image: Blood smear of child with acute lymphoblastic leukemia (Photo courtesy of Ohio State University).
Image: Dual-Luciferase Reporter Assay kit (Photo courtesy of Promega).
Image: Dual-Luciferase Reporter Assay kit (Photo courtesy of Promega).
Some familial platelet disorders are associated with predisposition to leukemia, myelodysplastic syndrome (MDS) or dyserythropoietic anemia.

A family with autosomal dominant thrombocytopenia, high erythrocyte mean corpuscular volume (MCV) and two occurrences of B cell–precursor acute lymphoblastic leukemia (ALL) have been identified.

An international team of scientists led by those at Wayne State University (Detroit, MI, USA) screened 23 families with similar phenotypes using whole-exome sequencing to identify a heterozygous single-nucleotide change in the oncogene Ets Variant 6 (ETV6).

ETV6 was initially identified as a tumor suppressor by its involvement in somatic translocations in childhood leukemia. The team found three families with germline mutations in ETV6 and defects in hematopoiesis.

The investigators used a battery of methods to identify variants in the gene. These included exome sequencing carried out on the HiSeq 2000 system (Illumina; San Diego, CA, USA); platelet and bone marrow ribonucleic acid (RNA) sequencing; luciferase reporter assays which were analyzed using the Dual-Luciferase Reporter Assay kit (Promega; Madison, WI, USA). The team also used high-resolution laser immunofluorescence confocal microscopy using a Quorum spinning-disc confocal inverted epifluorescence microscope (Olympus, Shinjuku, Tokyo, Japan).

Of the 23 families with similar phenotypes the team identified two with ETV6 mutations. One family also had a mutation encoding p.Pro214Leu and one individual with ALL. The other family had a c.1252A>G transition producing a p.Arg418Gly substitution in the DNA-binding domain, with alternative splicing and exon skipping. Functional characterization of these mutations showed aberrant cellular localization of mutant and endogenous ETV6, decreased transcriptional repression and altered megakaryocyte maturation. The findings underscore a key role for ETV6 in platelet formation and leukemia predisposition.

Michael Callaghan, MD, an assistant professor of Pediatrics and coauthor of the study said, “Our findings underscore a key role for ETV6 in platelet formation and leukemia predisposition and the mutation occurs through ‘aberrant cellular localization’ of the gene, which can result in ‘decreased transcriptional repression’ during white blood cell formation. What we think that means is that ETV6's job is to 'turn off' growth, but when you have this mutation, it can't turn it off because it's in the wrong place. It's usually supposed to sit on the DNA and keep things (including cancer) from getting made, but when you have this mutation, instead of sitting on the DNA it's sitting in a different part of the cell and that predisposes you to getting a (blood) cancer.” The study was published in the May 2015 issue of the journal Nature Genetics.

Related Links:

Wayne State University 
Illumina 
Promega 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.